Trial Profile
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cardiac angiography
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Adverse reactions
- 08 Feb 2013 New trial record